Together we will beat cancer

Donate

Cancer Research Technology Pioneer Fund boosts investment in drugs that block cancer defences

The Cancer Research Technology (CRT) Pioneer Fund has today announced its investment in research to develop new drugs.

Read More

Mapping cancer’s ‘social networks’ opens new approaches to treatment

Cancer Research UK scientists have designed a computer model that applies techniques used to analyse social networks to identify new ways of treating cancer.

Read More

Discovery could lead to more targeted drugs to stop cancer spread

Scientists have shed more light on a vital cluster of proteins that helps cells – including cancer cells – to move around the body

Read More

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP

Read More

Newcastle gets £5 million to boost drug development

Cancer Research UK’s Drug Discovery Committee has awarded the Northern Institute of Cancer Research £5M to bring more cancer drugs to clinic trials.

Read More

Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics to develop new oncology compound

Cancer Research UK, Cancer Research Technology (CRT) and Monopar Therapeutics LLC will take forward an antibody treatment HuATN-658 into clinical trials.

Read More

BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner

BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.

Read More

Cancer Research UK increases investment in drug development

Cancer Research UK is to increase investment by nearly 50 per cent over the next five years in its Centre for Drug Development.

Read More

International deal to screen potential cancer drugs using DNA ‘barcodes’

A screening technology tags compounds with strands of DNA to assess prototype drugs for anti-cancer activity.

Read More

Cancer Research UK and Lilly collaborate to trial combinations of potential new cancer treatments

Cancer Research UK’s Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.

Read More